Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $69.1K | $272.4K | $586.8K | $668.4K | $577.8K | $1.8M | $1.6M | $3.0M |
| Cost of revenue | $207.8K | $6.4K | $5.4K | $107.6K | $103.3K | $89.2K | $95.2K | $62.1K |
| Gross profit | −$138.7K | $266.0K | $581.4K | $560.8K | $474.4K | $1.7M | $1.5M | $2.9M |
| Gross margin | -200.7% | 97.6% | 99.1% | 83.9% | 82.1% | 95.0% | 94.0% | 97.9% |
| R&D | $1.1M | $975.4K | $1.8M | $1.9M | $4.9M | $4.5M | $10.2M | $10.7M |
| Operating income | −$3.2M | −$2.6M | −$3.6M | −$6.7M | −$8.7M | −$7.6M | −$13.3M | −$11.8M |
| EBITDA | −$3.2M | −$2.6M | −$3.6M | −$6.0M | −$8.1M | −$5.8M | −$11.4M | −$11.9M |
| Net income | −$2.8M | −$2.3M | −$2.9M | −$5.9M | −$8.1M | −$5.8M | −$11.4M | −$11.9M |
| Net margin | -3985.8% | -855.7% | -501.8% | -883.9% | -1395.1% | -326.9% | -720.3% | -401.6% |
| EPS (diluted) | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $912932 | $-0.02 | $-0.02–$-0.02 | 1 |
| 2027 | $11M | $-0.01 | $-0.01–$-0.01 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds ATHJF.
No tracked institution reports a position in ATHJF as of their last filing.
No one on the platform has traded ATHJF yet.
| $16M |
| — |
| OCELOrganicell Regenerative Medicine, Inc. | $2.74 | -0.27% | $20M | — |
| PKANFSimply Better Brands Corp. | $0.21 | -16.39% | $15M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 11.4× sales vs its 22.1× historical median P/S.
Fair value ≈ $0.10 · price $0.05 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$ATHJF Is this broke crap?? please somebody DD this with me before I gamble away my money $BNBX $APLT $CRVS
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.